Editas Medicine appoints Dan Ory as chief medical officer

Editas Medicine appoints Dan Ory as chief medical officer
Editas Medicine names Dan Ory CMO

Editas Medicine has announced the appointment of Dan Ory, M.D., as its new chief medical officer.

The company shared the leadership change in an update, adding that additional details are available in a press release. Editas Medicine highlighted the move as part of its evolving focus in gene editing and cardiovascular disease.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.